Effects of spray drying conditions on the physicochemical properties of the Tramadol-Hcl microparticles containing Eudragit® RS and RL

Journal of Pharmacy and Bioallied Sciences

Volumn 4, Issue SUPPL., 2012, Pages 50-53

  Patel, A S ^a   Soni, T ^a   Thakkar, V ^a   Gandhi, T ^a  

^a ANAND PHARMACY COLLEGE   (India)

Author keywords

Eudragit ; microspheres; spray drying parameters; Tramadol

Indexed keywords

EUDRAGIT; EUDRAGIT RS; TRAMADOL;

CONFERENCE PAPER; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG STABILITY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MICROENCAPSULATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SPRAY DRYING; STRUCTURE ANALYSIS; THERMAL ANALYSIS; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION;

EID: 84860456323     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.94134     Document Type: Conference Paper

References (11)

1. Botti BY and Nusrat MT.Optimization of experimental parameters for the production of LMWH-loaded polymeric microspheres.Drug Design Development and Therapy 2008;2: p 39-48.
2. Corrigan D. Preparation and release of salbutamol from chitosan and chitosanco-spray dried compacts and multiparticulates. European journal of pharmaceutics and biopharmaceutics 2006;62:295-305. (Pubitemid 43356579)
3. Ammar H.O., Polymeric Matrix System for Prolonged Delivery of Tramadol Hydrochloride, Part I: Physicochemical Evaluation, J Control Release Back Issue.
4. Bodmeier R, Chen H. Preparation and characterization of microspheres containing the anti-inflammatory agents, Indomethacin, Ibuprofen and Ketoprofen. J Controlled Release 1989;10:167-175. (Pubitemid 19259948)
5. Broadhead, J., Rouan, S.K.E., Rhodes, C.T., The spray drying of pharmaceuticals. Drug Dev Ind Pharm 1992;8:1169-1206.
6. Bolton S. Pharmaceutical Statistics. Second ed. Marcel Decker, New York, USA, 1990;234.
7. Esposito E., Roncarati R., Cortesi R., Cervellati F., Nastruzzi C., Production of Eudragit microparticles by spray-drying technique: Influence of experimental parameters on morphological and dimensional characteristics, Pharm Dev Technol 2000;5:267-278. (Pubitemid 30247107)
8. Franz RM, Browne JE, Lewis AE. Experiment design, modeling and optimization strategies for product and process development. In: Libermann HA, Reiger MM, Banker GS, eds. Pharmaceutical Dosage Forms: Disperse Systems. Marcel Dekker, New York, USA, 1988;1:427-519.
9. George M, Grass IV, Robinson JR. Sustained and controlled release delivery systems, Marcel Dekker, New York, USA, 1978:124-127.
10. Gohel M.C., Amin A F. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J Controlled Release 1998;51:115-122. (Pubitemid 28252862)
11. Harish N. M., Improved Bioavailability of pefloxacin by formulationg controlled release ocular inserts. Int J Pharm Sci and Research 2009.